Miromatrix Medical, Inc. (MIRO)
| Market Cap | 137.55M |
| Revenue (ttm) | 41,295 |
| Net Income (ttm) | n/a |
| Shares Out | 2.91M |
| EPS (ttm) | -3.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 88,544 |
| Open | 7.73 |
| Previous Close | 7.75 |
| Day's Range | 6.86 - 8.29 |
| 52-Week Range | 6.86 - 16.52 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | 22.00 (+220.7%) |
| Est. Earnings Date | n/a |
About MIRO
Miromatrix Medical is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. We have developed a proprietary perfusion technology platform for bioengineering organs that we believe will efficiently scale to address the shortage of available human organs. Our perfusion decellularization and recellularization technology platform includes 118 issued and 35 pending patent applications, with protection in the United States and major markets worldwide. Our...
Financial Performance
In 2020, MIRO's revenue was $46,530, a decrease of -81.39% compared to the previous year's $250,000. Losses were -$10.31 million, 154.8% more than in 2019.
Financial StatementsNews
Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys
The biotechnology company working to eliminate the organ transplant waitlist outlines expansion of its clinical work, supported by IPO funds and Series C round, led by Baxter, CareDx, and DaVita The bio...
Miromatrix Medical Announces Closing of Initial Public Offering
EDEN PRAIRIE, Minn., June 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully transplantabl...
Miromatrix Medical Announces Pricing of Upsized Initial Public Offering
EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully transplantabl...
Miromatrix Medical IPO Registration Document (S-1)
Miromatrix Medical, Inc. has filed to go public with an IPO on the NASDAQ.